Teza Capital Management LLC Raises Stock Holdings in The Clorox Company (NYSE:CLX)

Teza Capital Management LLC increased its holdings in The Clorox Company (NYSE:CLX - Free Report) by 766.4% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 13,741 shares of the company's stock after purchasing an additional 12,155 shares during the period. Teza Capital Management LLC's holdings in Clorox were worth $2,232,000 as of its most recent SEC filing.

A number of other large investors also recently added to or reduced their stakes in the business. Integral Investment Advisors Inc. lifted its holdings in Clorox by 4.1% in the 4th quarter. Integral Investment Advisors Inc. now owns 1,718 shares of the company's stock worth $279,000 after purchasing an additional 67 shares in the last quarter. Sound View Wealth Advisors Group LLC raised its holdings in shares of Clorox by 6.1% during the 4th quarter. Sound View Wealth Advisors Group LLC now owns 1,345 shares of the company's stock worth $218,000 after acquiring an additional 77 shares in the last quarter. Wedbush Securities Inc. raised its holdings in shares of Clorox by 1.2% during the 4th quarter. Wedbush Securities Inc. now owns 7,624 shares of the company's stock worth $1,238,000 after acquiring an additional 94 shares in the last quarter. Brooklyn Investment Group raised its holdings in shares of Clorox by 163.8% during the 4th quarter. Brooklyn Investment Group now owns 153 shares of the company's stock worth $25,000 after acquiring an additional 95 shares in the last quarter. Finally, Global X Japan Co. Ltd. raised its holdings in shares of Clorox by 3.0% during the 4th quarter. Global X Japan Co. Ltd. now owns 3,272 shares of the company's stock worth $531,000 after acquiring an additional 95 shares in the last quarter. 78.53% of the stock is owned by hedge funds and other institutional investors.

Clorox Stock Down 2.7%

Shares of CLX traded down $3.61 during midday trading on Wednesday, reaching $131.90. 1,944,245 shares of the stock were exchanged, compared to its average volume of 1,327,670. The Clorox Company has a 52 week low of $127.60 and a 52 week high of $171.37. The company has a current ratio of 0.94, a quick ratio of 0.60 and a debt-to-equity ratio of 20.52. The company's 50 day moving average is $140.57 and its two-hundred day moving average is $152.97. The company has a market capitalization of $16.26 billion, a P/E ratio of 36.04, a PEG ratio of 2.62 and a beta of 0.60.

Clorox (NYSE:CLX - Get Free Report) last posted its quarterly earnings results on Monday, May 5th. The company reported $1.45 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.57 by ($0.12). Clorox had a return on equity of 316.87% and a net margin of 6.38%. The firm had revenue of $1.67 billion for the quarter, compared to the consensus estimate of $1.74 billion. During the same period in the previous year, the company posted $1.71 EPS. Clorox's quarterly revenue was down 8.0% compared to the same quarter last year. On average, sell-side analysts anticipate that The Clorox Company will post 7.15 earnings per share for the current year.

Clorox Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, May 9th. Stockholders of record on Wednesday, April 23rd were given a dividend of $1.22 per share. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.70%. The ex-dividend date was Wednesday, April 23rd. Clorox's payout ratio is 87.61%.

Wall Street Analysts Forecast Growth

CLX has been the topic of several recent research reports. DA Davidson decreased their price objective on Clorox from $171.00 to $169.00 and set a "neutral" rating on the stock in a report on Wednesday, February 5th. Wells Fargo & Company decreased their price target on Clorox from $145.00 to $142.00 and set an "equal weight" rating on the stock in a report on Tuesday, May 6th. Royal Bank of Canada restated a "sector perform" rating and set a $150.00 price target on shares of Clorox in a report on Thursday, January 30th. Evercore ISI set a $140.00 price target on Clorox and gave the company an "underperform" rating in a report on Tuesday, May 6th. Finally, JPMorgan Chase & Co. decreased their price target on Clorox from $151.00 to $144.00 and set a "neutral" rating on the stock in a report on Tuesday, May 6th. Three investment analysts have rated the stock with a sell rating, eleven have assigned a hold rating and one has given a buy rating to the company. Based on data from MarketBeat.com, Clorox currently has a consensus rating of "Hold" and an average target price of $151.23.

Insider Buying and Selling

In related news, Director Pierre R. Breber acquired 4,000 shares of the firm's stock in a transaction that occurred on Wednesday, May 7th. The stock was purchased at an average cost of $136.57 per share, for a total transaction of $546,280.00. Following the purchase, the director now directly owns 4,000 shares of the company's stock, valued at $546,280. This trade represents a ∞ increase in their position. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this link. 0.57% of the stock is currently owned by company insiders.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.